BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29207107)

  • 1. Modular organization of a hypocretin gene minimal promoter.
    Sánchez-García A; Cabral-Pacheco GA; Zomosa-Signoret VC; Ortiz-López R; Camacho A; Tabera-Tarello PM; Garnica-López JA; Vidaltamayo R
    Mol Med Rep; 2018 Feb; 17(2):2263-2270. PubMed ID: 29207107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gene encoding the mouse contactin-1 axonal glycoprotein is regulated by the collier/Olf1/EBF family early B-Cell factor 2 transcription factor.
    Bizzoca A; Picocci S; Corsi P; Arbia S; Croci L; Consalez GG; Gennarini G
    Dev Neurobiol; 2015 Dec; 75(12):1420-40. PubMed ID: 25820347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEC2 modulates orexin expression and regulates sleep.
    Hirano A; Hsu PK; Zhang L; Xing L; McMahon T; Yamazaki M; Ptáček LJ; Fu YH
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3434-3439. PubMed ID: 29531056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: identification of alternative promoters.
    Chen J; Randeva HS
    Biochem J; 2010 Apr; 427(3):377-90. PubMed ID: 20156195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin signaling regulates hypothalamic expression of nescient helix-loop-helix 2 (Nhlh2) through signal transducer and activator 3 (Stat3).
    Al Rayyan N; Zhang J; Burnside AS; Good DJ
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):134-42. PubMed ID: 24486192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of PLAGL1/ZAC1 in hypocretin/orexin transcription.
    Tanaka S; Honda Y; Takaku S; Koike T; Oe S; Hirahara Y; Yoshida T; Takizawa N; Takamori Y; Kurokawa K; Kodama T; Yamada H
    Int J Mol Med; 2019 May; 43(5):2164-2176. PubMed ID: 30896835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential promoter usage in prolactin receptor gene expression: hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver.
    Møldrup A; Ormandy C; Nagano M; Murthy K; Banville D; Tronche F; Kelly PA
    Mol Endocrinol; 1996 Jun; 10(6):661-71. PubMed ID: 8776726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    Mårtensson UE; Bristulf J; Owman C; Olde B
    Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional characterizations of the 5'-flanking region of the mouse glucagon receptor gene: comparison with the rat gene.
    Geiger A; Decaux JF; Burcelin R; Le Cam A; Salazar G; Charron MJ; Girard J; Kervran A
    Biochem Biophys Res Commun; 2000 Jun; 272(3):912-21. PubMed ID: 10860851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene.
    Sugawara T; Holt JA; Kiriakidou M; Strauss JF
    Biochemistry; 1996 Jul; 35(28):9052-9. PubMed ID: 8703908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexins/hypocretins increase the promoter activity of selective steroidogenic enzymes.
    Kagerer SM; Eichholz C; Jöhren O
    Peptides; 2011 Apr; 32(4):839-43. PubMed ID: 21256172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells.
    Fang MA; Glackin CA; Sadhu A; McDougall S
    J Cell Biochem; 2001; 80(4):550-9. PubMed ID: 11169739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer.
    Coulson JM; Fiskerstrand CE; Woll PJ; Quinn JP
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):961-70. PubMed ID: 10585887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems.
    Jin H; Romano G; Marshall C; Donaldson AE; Suon S; Iacovitti L
    J Cell Physiol; 2006 Apr; 207(1):49-57. PubMed ID: 16252282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distal region of the human TGM1 promoter is required for expression in transgenic mice and cultured keratinocytes.
    Phillips MA; Jessen BA; Lu Y; Qin Q; Stevens ME; Rice RH
    BMC Dermatol; 2004 Apr; 4():2. PubMed ID: 15061870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice.
    De La Herrán-Arita AK; Zomosa-Signoret VC; Millán-Aldaco DA; Palomero-Rivero M; Guerra-Crespo M; Drucker-Colín R; Vidaltamayo R
    Neuroscience; 2011 Jun; 183():134-43. PubMed ID: 21435382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
    Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PRPF31 and TFPT: regulation in health and retinal disease.
    Rose AM; Shah AZ; Waseem NH; Chakarova CF; Alfano G; Coussa RG; Ajlan R; Koenekoop RK; Bhattacharya SS
    Hum Mol Genet; 2012 Sep; 21(18):4126-37. PubMed ID: 22723017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.